685 related articles for article (PubMed ID: 33801464)
1. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Oh SJ; Shin OS
Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
[TBL] [Abstract][Full Text] [Related]
2. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
Chang CY; Liu HM; Chang MF; Chang SC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
4. The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
Hu Y; Li W; Gao T; Cui Y; Jin Y; Li P; Ma Q; Liu X; Cao C
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148787
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452305
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1.
Sui L; Zhao Y; Wang W; Wu P; Wang Z; Yu Y; Hou Z; Tan G; Liu Q
Front Immunol; 2021; 12():662989. PubMed ID: 34084167
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production.
Chen K; Xiao F; Hu D; Ge W; Tian M; Wang W; Pan P; Wu K; Wu J
Viruses; 2020 Dec; 13(1):. PubMed ID: 33396605
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
12. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets.
Yang Y; Ye F; Zhu N; Wang W; Deng Y; Zhao Z; Tan W
Sci Rep; 2015 Dec; 5():17554. PubMed ID: 26631542
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101
[TBL] [Abstract][Full Text] [Related]
14. A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-β Production by Inducing Ubiquitination of RIG-I.
Liu Y; Liang QZ; Lu W; Yang YL; Chen R; Huang YW; Wang B
Front Immunol; 2021; 12():688758. PubMed ID: 34220846
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box O1-mediated ubiquitination suppresses RIG-I-mediated antiviral immune responses.
Ma Z; Zhang W; Fan W; Wu Y; Zhang M; Xu J; Li W; Sun L; Liu W; Liu W
Int Immunopharmacol; 2021 Jan; 90():107152. PubMed ID: 33187908
[TBL] [Abstract][Full Text] [Related]
16. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.
Lui PY; Wong LY; Fung CL; Siu KL; Yeung ML; Yuen KS; Chan CP; Woo PC; Yuen KY; Jin DY
Emerg Microbes Infect; 2016 Apr; 5(4):e39. PubMed ID: 27094905
[TBL] [Abstract][Full Text] [Related]
17. Swine Acute Diarrhea Syndrome Coronavirus Nucleocapsid Protein Antagonizes Interferon-
Zhou Z; Sun Y; Xu J; Tang X; Zhou L; Li Q; Lan T; Ma J
Front Immunol; 2021; 12():573078. PubMed ID: 33692778
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
Yang DM; Geng TT; Harrison AG; Wang PH
Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908
[TBL] [Abstract][Full Text] [Related]
19. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
Lee Y; Song B; Park C; Kwon KS
PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
[TBL] [Abstract][Full Text] [Related]
20. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]